Analgesic Solutions Presents Data On The Use Of MADDERS To Assess Potentially Abuse-Related Events In Clinical Trials At The Post author:Sam Post published:June 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like AbbVie’s Elagolix Dazzles in Phase III Trial March 12, 2018 Health Insurer Cigna Paying $67 Billion to Buy Express Script March 7, 2018 SoCal's Artelo Biosciences Inks $202M+ R&D Deal With the NEOMED Institute January 29, 2018